Loading organizations...
Loading organizations...
Develops novel antibiotics to combat drug-resistant bacterial infections.
MicuRx Pharmaceuticals has raised $90.9M across 4 funding rounds.
MicuRx Pharmaceuticals has raised $90.9M in total across 4 funding rounds.
MicuRx Pharmaceuticals has raised $90.9M in total across 4 funding rounds.
MicuRx Pharmaceuticals's investors include BVCF Management, Delian Capital, GP Capital, 3E Bioventures Capital, GP TMT Capital, Davis Yang, Devon Park Bioventures, Morningside.
MicuRx Pharmaceuticals has raised $90.9M across 4 funding rounds. Most recently, it raised $890K Other Equity in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 6, 2017 | $890K Other Equity | BVCF Management, Delian Capital | |
| Sep 26, 2016 | $55.0M Series C | GP Capital | 3E Bioventures Capital, Delian Capital, GP TMT Capital |
| Aug 22, 2013 | $25.0M Series B | Davis Yang | Devon Park Bioventures, Morningside |
| Jun 26, 2007 | $10.0M Other Equity | Morningside |